Related references
Note: Only part of the references are listed.Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Molnupiravir: A new candidate for COVID-19 treatment
Fariba Pourkarim et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
J. Ryan Bariola et al.
OPEN FORUM INFECTIOUS DISEASES (2021)